ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,580 | -3.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2023 | $3,690 | +11.5% | 1,000 | 0.0% | 0.00% | – |
Q1 2023 | $3,310 | -14.7% | 1,000 | 0.0% | 0.00% | – |
Q4 2022 | $3,880 | +94.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | -80.0% | 1,000 | -75.0% | 0.00% | – |
Q3 2021 | $5,000 | -16.7% | 4,000 | 0.0% | 0.00% | – |
Q2 2021 | $6,000 | -100.0% | 4,000 | -50.0% | 0.00% | – |
Q1 2021 | $14,080,000 | +175900.0% | 8,000 | +100.0% | 0.00% | – |
Q4 2020 | $8,000 | -20.0% | 4,000 | 0.0% | 0.00% | – |
Q3 2020 | $10,000 | +233.3% | 4,000 | +300.0% | 0.00% | – |
Q2 2020 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2019 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2019 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 5,269,155 | $12,804,000 | 12.70% |
Stonepine Capital Management, LLC | 5,000,000 | $12,150,000 | 5.46% |
Altium Capital Management LP | 2,883,710 | $7,007,000 | 2.57% |
AWM Investment Company, Inc. | 5,015,000 | $12,186,000 | 1.85% |
Potomac Capital Management, Inc. | 482,000 | $1,171,000 | 1.34% |
Perceptive Advisors | 10,933,387 | $26,568,000 | 0.77% |
EAM Investors, LLC | 1,427,160 | $3,468,000 | 0.75% |
Clearline Capital LP | 2,496,297 | $6,066,000 | 0.72% |
EAM Global Investors LLC | 836,323 | $2,032,000 | 0.54% |
BOOTHBAY FUND MANAGEMENT, LLC | 8,121,153 | $19,734,000 | 0.49% |